Corticobasal Syndrome (CBS): Clinical Trials

7 trials for Corticobasal Syndrome (CBS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Corticobasal Syndrome (CBS): new trials by email Literature Review of Corticobasal Syndrome (CBS) trials Research Report on Corticobasal Syndrome (CBS)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD)
Not yet recruitingBioSensics602026-11-012026-10-13
Imaging Studies in Corticobasal Syndrome
C-11 ER176 Radiotracer, C-11 PiB, AV1451 Tau - Cortico Basal Degeneration, Corticobasal Syndrome
RecruitingJennifer Whitwell802025-06-252026-07-14
The CurePSP Genetics Program
Whole genome sequencing will be performed at the NIH - PSP, PSP - Progressive Supranuclear Palsy
RecruitingMassachusetts General Hospital10002024-10-082026-01-14
PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)
RAVICTI 1.1 g/ml, Placebo - Corticobasal Syndrome (CBS)
Phase 2CompletedTechnical University of Munich322023-12-122026-09-11
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Observational Study - Corticobasal Degeneration (CBD), Corticobasal Syndrome (CBS)
CompletedUniversity of California, San Francisco2932016-01-012025-04-13
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
FTLD, Progressive Supranuclear Palsy (PSP)
CompletedUniversity of California, San Francisco14892014-09-012021-05-21
Safety Study of TPI-287 to Treat CBS and PSP
TPI 287 2 mg/m2, TPI-287 20 mg/m2, Placebo - Primary Four Repeat Tauopathies (4RT), Corticobasal Syndrome (CBS)
Phase 1CompletedUniversity of California, San Francisco442014-05-012020-04-15

Narrower conditions

Corticobasal Degeneration (7)  ·  Supranuclear Palsy, Progressive (4)  ·  Color Vision Defects (3)  ·  Frontotemporal Dementia (2)  ·  Frontotemporal Lobar Degeneration (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Multiple System Atrophy (1)  ·  Multiple system atrophy (MSA) with orthostatic hypotension (1)  ·  Nerve Degeneration (1)  ·  Neurodegenerative Diseases (1)  ·  Pick Disease of the Brain (1)  ·  Primary Progressive Nonfluent Aphasia (1)  ·  Shy-Drager Syndrome (1)

Broader conditions

Nervous System Diseases (7)  ·  Tauopathies (7)  ·  Neurodegenerative Diseases (6)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Eye Diseases (5)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Basal Ganglia Diseases (4)  ·  Cranial Nerve Diseases (4)  ·  Movement Disorders (4)  ·  Ocular Motility Disorders (4)  ·  Ophthalmoplegia (4)  ·  Paralysis (4)

Interventions

Observation (1)  ·  TPI-287 (1)  ·  glycerol phenylbutyrate (1)

Sponsors

University of California, San Francisco (3)  ·  BioSensics (1)  ·  Jennifer Whitwell (1)  ·  Massachusetts General Hospital (1)  ·  Technical University of Munich (1)

Countries

United States (6)  ·  Canada (2)  ·  Germany (1)

Top investigators

Adam L Boxer, MD, PhD (2)  ·  Adam Boxer, MD, PhD (1)  ·  Jennifer Whitwell, Ph.D. (1)

Results publications

PMID 31710340, PMID 33827960, PMID 35492244, PMID 35790423, PMID 38578117, PMID 38959435, PMID 42400090

NIH funding

R01AG038791 (1), R01AG087140 (1), U54NS092089 (1)